Adamas Pharmaceuticals Inc (ADMS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Gregory T. Went
Employees:
159
1900 POWELL ST., SUITE 750, EMERYVILLE, CA 94608
510-450-3554

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Adamas Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in discovering chrono-synchronous therapies. It involves in the development and commercialization of therapeutics targeting chronic disorders of the central nervous system. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.

Data derived from most recent annual or quarterly report
Market Cap 374.798 Million Shares Outstanding45.596 Million Avg 30-day Volume 827.831 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.63
Price to Revenue2.5398 Debt to Equity-5.9723 EBITDA-38.749 Million
Price to Book Value0.0 Operating Margin-44.5554 Enterprise Value241.932 Million
Current Ratio4.53 EPS Growth0.226 Quick Ratio3.907
1 Yr BETA -0.0783 52-week High/Low 9.15 / 4.02 Profit Margin-71.1064
Operating Cash Flow Growth20.2423 Altman Z-Score-4.1204 Free Cash Flow to Firm -21.137 Million
View SEC Filings from ADMS instead.

View recent insider trading info

Funds Holding ADMS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ADMS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2021-11-24:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-06-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-06-04:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-02-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-02-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-02-01:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2021-01-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DEMSKI MARTHA J

    • Director
    0 2021-11-24 1

    RICHO ANNA

    • Director
    0 2021-11-24 1

    BIGHAM MICHAEL

    • Director
    0 2021-11-24 1

    MAHONEY DAVID L

    • Director
    0 2021-11-24 1

    MACPHEE JOHN A

    • Director
    0 2021-11-24 1

    ERICSON WILLIAM W.

    • Director
    • 10% Owner
    0 2021-11-24 1

    MCFARLANE NEIL F. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2021-11-24 1

    PRENTISS CHRISTOPHER B CHIEF FINANCIAL OFFICER

    • Officer
    0 2021-11-24 1

    SHREEDHAR VIJAY CHIEF COMMERCIAL OFFICER

    • Officer
    0 2021-11-24 1

    PAPAPETROPOULOS SPYRIDON

    • Director
    0 2021-11-24 1

    DIER MARDI

    • Director
    20,000 2021-06-02 0

    LIEBERBURG IVAN M

    • Director
    69,000 2020-06-03 0

    MERRIWEATHER ALFRED G CHIEF FINANCIAL OFFICER

    • Officer
    48,019 2019-09-20 0

    RHODES JENNIFER J CBO, GC & COMPLIANCE OFFICER

    • Officer
    63,114 2019-06-20 0

    WENT GREGORY T CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    431,783 2019-04-08 0

    PATNI RAJIV CHIEF MEDICAL OFFICER

    • Officer
    49,141 2019-04-08 0

    KING RICHARD CHIEF OPERATING OFFICER

    • Officer
    48,856 2018-06-21 0

    GREAT POINT PARTNERS LLC

    JAY JEFFREY R

    KROIN DAVID

    • 10% Owner
    No longer subject to file 2017-06-19 0

    BOOTH RICHARD H

    • Director
    0 2017-06-01 0

    DAWSON WILLIAM J CHIEF FINANCIAL OFFICER

    • Officer
    14,284 2017-03-21 0

    MDV IX LP

    SEVENTH MDV PARTNERS, L.L.C.

    NINTH MDV PARTNERS, L.L.C.

    FEIBER JONATHAN D

    SCHOENDORF NANCY J

    MDV ENF VII (A), L.P.

    MDV ENF VII (B), L.P.

    MDV VII LEADERS' FUND, L.P.

    MDV VII LP

    • 10% Owner
    4,031,804 2016-09-14 0

    MCCLURE NATALIE SVP, PRODUCT DEVELOPMENT

    • Officer
    8,340 2016-04-18 0

    LEWIS SARA GROOTWASSINK

    • Director
    0 2015-05-14 0

    AERIS CAPITAL EQUITY INVESTMENTS, L.P.

    • 10% Owner
    1,662,128 2015-03-13 0

    KNAPP JEFFREY H CHIEF OPERATING OFFICER

    • Officer
    0 2015-02-25 0

    SHIN GRACE GENERAL COUNSEL

    • Officer
    0 2014-12-01 0

    DAG VENTURES MANAGEMENT III, LLC

    DAG VENTURES III-QP LP

    DAG VENTURES III, L.P.

    DAG VENTURES GP FUND III, LLC

    CADEDDU JOHN J.

    GOODRICH R. THOMAS

    • 10% Owner
    1,660,229 2014-04-15 0

    MDV IX LP

    NINTH MDV PARTNERS, L.L.C.

    FEIBER JONATHAN D

    MDV VII LP

    SEVENTH MDV PARTNERS, L.L.C.

    SCHOENDORF NANCY J

    • 10% Owner
    2,742,702 2014-04-09 0

    COFFEE MICHAEL DENIS SENIOR VP, STRATEGY & PLANNING

    • Officer
    0 2014-04-09 0

    RIMAC ANTHONY M CHIEF FINANCIAL OFFICER

    • Officer
    0 2014-04-09 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 22:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 21:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 21:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 20:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 20:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 19:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 19:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 18:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 18:15:04 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 17:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 17:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 16:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 16:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 15:45:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 15:15:03 UTC -0.4667 0.5367 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 14:45:03 UTC -0.4139 0.4839 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 14:15:03 UTC -0.4139 0.4839 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 13:45:03 UTC -0.4139 0.4839 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 13:15:03 UTC -0.4139 0.4839 650000
    ADAMAS PHARMACEUTICALS INC ADMS 2021-11-24 12:45:03 UTC -0.4139 0.4839 650000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments